These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19690177)

  • 1. Polymorphic variants in hereditary pancreatic cancer genes are not associated with pancreatic cancer risk.
    McWilliams RR; Bamlet WR; de Andrade M; Rider DN; Couch FJ; Cunningham JM; Matsumoto ME; Rabe KG; Hammer TJ; Petersen GM
    Cancer Epidemiol Biomarkers Prev; 2009 Sep; 18(9):2549-52. PubMed ID: 19690177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleotide excision repair pathway polymorphisms and pancreatic cancer risk: evidence for role of MMS19L.
    McWilliams RR; Bamlet WR; de Andrade M; Rider DN; Cunningham JM; Petersen GM
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1295-302. PubMed ID: 19318433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of mitotic regulation pathway polymorphisms with pancreatic cancer risk and outcome.
    Couch FJ; Wang X; Bamlet WR; de Andrade M; Petersen GM; McWilliams RR
    Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):251-7. PubMed ID: 20056645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of breast cancer susceptibility variants with risk of pancreatic cancer.
    Couch FJ; Wang X; McWilliams RR; Bamlet WR; de Andrade M; Petersen GM
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3044-8. PubMed ID: 19843670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of germline genetic mutations in patients with pancreatic cancer.
    Salo-Mullen EE; O'Reilly EM; Kelsen DP; Ashraf AM; Lowery MA; Yu KH; Reidy DL; Epstein AS; Lincoln A; Saldia A; Jacobs LM; Rau-Murthy R; Zhang L; Kurtz RC; Saltz L; Offit K; Robson ME; Stadler ZK
    Cancer; 2015 Dec; 121(24):4382-8. PubMed ID: 26440929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Common Susceptibility Variants of Pancreatic Cancer in Higher-Risk Patients: A PACGENE Study.
    Childs EJ; Chaffee KG; Gallinger S; Syngal S; Schwartz AG; Cote ML; Bondy ML; Hruban RH; Chanock SJ; Hoover RN; Fuchs CS; Rider DN; Amundadottir LT; Stolzenberg-Solomon R; Wolpin BM; Risch HA; Goggins MG; Petersen GM; Klein AP
    Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1185-91. PubMed ID: 27197284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single Nucleotide Polymorphism in Adiponectin Gene and Risk of Pancreatic Adenocarcinoma.
    Mohamed AA; Omar H; Ghaffar MFA; Marie MS; Ramadan MEA; Talima SM; Daly M; Mahmoud S
    Asian Pac J Cancer Prev; 2019 Jan; 20(1):139-143. PubMed ID: 30678425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations.
    Lal G; Liu G; Schmocker B; Kaurah P; Ozcelik H; Narod SA; Redston M; Gallinger S
    Cancer Res; 2000 Jan; 60(2):409-16. PubMed ID: 10667595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRCA2 mutations as a universal risk factor for pancreatic cancer has a limited role in Korean ethnic group.
    Cho JH; Bang S; Park SW; Chung JB; Song SY
    Pancreas; 2008 May; 36(4):337-40. PubMed ID: 18437078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased prevalence of the BRCA2 polymorphic stop codon K3326X among individuals with familial pancreatic cancer.
    Martin ST; Matsubayashi H; Rogers CD; Philips J; Couch FJ; Brune K; Yeo CJ; Kern SE; Hruban RH; Goggins M
    Oncogene; 2005 May; 24(22):3652-6. PubMed ID: 15806175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PALB2 analysis in BRCA2-like families.
    Adank MA; van Mil SE; Gille JJ; Waisfisz Q; Meijers-Heijboer H
    Breast Cancer Res Treat; 2011 Jun; 127(2):357-62. PubMed ID: 20582465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer.
    Hu C; Hart SN; Polley EC; Gnanaolivu R; Shimelis H; Lee KY; Lilyquist J; Na J; Moore R; Antwi SO; Bamlet WR; Chaffee KG; DiCarlo J; Wu Z; Samara R; Kasi PM; McWilliams RR; Petersen GM; Couch FJ
    JAMA; 2018 Jun; 319(23):2401-2409. PubMed ID: 29922827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes.
    Slavin TP; Neuhausen SL; Nehoray B; Niell-Swiller M; Solomon I; Rybak C; Blazer K; Adamson A; Yang K; Sand S; Guerrero-Llamas N; Castillo D; Herzog J; Wu X; Tao S; Raja S; Chung V; Singh G; Nadesan S; Brown S; Cruz-Correa M; Petersen GM; Weitzel J;
    Fam Cancer; 2018 Apr; 17(2):235-245. PubMed ID: 28687971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential functional variants in SMC2 and TP53 in the AURORA pathway genes and risk of pancreatic cancer.
    Feng Y; Liu H; Duan B; Liu Z; Abbruzzese J; Walsh KM; Zhang X; Wei Q
    Carcinogenesis; 2019 Jun; 40(4):521-528. PubMed ID: 30794721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDKN2A is the main susceptibility gene in Italian pancreatic cancer families.
    Ghiorzo P; Fornarini G; Sciallero S; Battistuzzi L; Belli F; Bernard L; Bonelli L; Borgonovo G; Bruno W; De Cian F; Decensi A; Filauro M; Faravelli F; Gozza A; Gargiulo S; Mariette F; Nasti S; Pastorino L; Queirolo P; Savarino V; Varesco L; Scarrà GB;
    J Med Genet; 2012 Mar; 49(3):164-70. PubMed ID: 22368299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of common variants in BRCA2 and MAP2K4 for susceptibility to sporadic pancreatic cancer.
    Huang L; Wu C; Yu D; Wang C; Che X; Miao X; Zhai K; Chang J; Jiang G; Yang X; Cao G; Hu Z; Zhou Y; Zuo C; Wang C; Zhang X; Zhou Y; Yu X; Dai W; Li Z; Shen H; Liu L; Chen Y; Zhang S; Wang X; Liu Y; Sun M; Cao W; Gao J; Ma Y; Zheng X; Cheung ST; Jia Y; Tan W; Wu T; Lin D
    Carcinogenesis; 2013 May; 34(5):1001-5. PubMed ID: 23299404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inherited pancreatic cancer syndromes.
    Solomon S; Das S; Brand R; Whitcomb DC
    Cancer J; 2012; 18(6):485-91. PubMed ID: 23187834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are BRCA1 and BRCA2 gene mutation patients underscreened for pancreatic adenocarcinoma?
    Roch AM; Schneider J; Carr RA; Lancaster WP; House MG; Zyromski NJ; Nakeeb A; Schmidt CM; Ceppa EP
    J Surg Oncol; 2019 May; 119(6):777-783. PubMed ID: 30636051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA1 missense polymorphisms are associated with poor prognosis of pancreatic cancer patients in a Chinese population.
    Zhu Y; Zhai K; Ke J; Li J; Gong Y; Yang Y; Tian J; Zhang Y; Zou D; Peng X; Gong J; Zhong R; Huang K; Chang J; Miao X
    Oncotarget; 2017 May; 8(22):36033-36039. PubMed ID: 28415599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial pancreatic cancer syndromes.
    Habbe N; Langer P; Sina-Frey M; Bartsch DK
    Endocrinol Metab Clin North Am; 2006 Jun; 35(2):417-30, xi. PubMed ID: 16632103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.